Literature DB >> 12960252

Clearance of apoptotic cells: TGF-beta in the balance between inflammation and fibrosis.

Robert M Clancy, Jill P Buyon.   

Abstract

Transforming growth factor-beta (TGF-beta) has been considered an anti-inflammatory cytokine responsible for the bland removal of apoptotic cells. What is less established is the extent of secretion of this cytokine during the clearance of opsonized apoptotic cells via Fcgamma-mediated uptake. To date both decreased (favoring predominance of inflammation) and increased (favoring resolution of inflammation but potentially pro-fibrotic) responses have been demonstrated. IN an in vitro model of autoantibody-induced cardiac injury, we herein demonstrate that macrophages cocultured with apoptotic human fetal cardiocytes bound by anti-SSA/Ro antibodies secrete increased levels of TGF-beta. Prolonged secretion of this cytokine may contribute to the exuberant scarring seen in congenital heart block associated with maternal autoantibodies reactive with SSA/Rho and SSB/La antigens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960252     DOI: 10.1189/jlb.0603276

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Activation of the transforming growth factor beta pathway in bacterial otitis media.

Authors:  Yun-Woo Lee; Yunju Chung; Steven K Juhn; Youngki Kim; Jizhen Lin
Journal:  Ann Otol Rhinol Laryngol       Date:  2011-03       Impact factor: 1.547

2.  MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1.

Authors:  Alexandra L McCubbrey; Joshua D Nelson; Valerie R Stolberg; Pennelope K Blakely; Lisa McCloskey; William J Janssen; Christine M Freeman; Jeffrey L Curtis
Journal:  J Immunol       Date:  2015-12-30       Impact factor: 5.422

3.  Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block.

Authors:  Robert M Clancy; Petra J Neufing; Ping Zheng; Marguerita O'Mahony; Falk Nimmerjahn; Tom P Gordon; Jill P Buyon
Journal:  J Clin Invest       Date:  2006-08-10       Impact factor: 14.808

Review 4.  Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.

Authors:  Kelli P A MacDonald; Geoffrey R Hill; Bruce R Blazar
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

5.  Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case series.

Authors:  Piergiorgio Neri; Mara Manoni; Cinzia Fortuna; Marta Lettieri; Cesare Mariotti; Alfonso Giovannini
Journal:  Int Ophthalmol       Date:  2009-09-02       Impact factor: 2.031

6.  Stability analysis of a model for foreign body fibrotic reactions.

Authors:  A Ibraguimov; L Owens; J Su; L Tang
Journal:  Comput Math Methods Med       Date:  2012-09-13       Impact factor: 2.238

7.  Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease.

Authors:  Vedran Radojcic; Maria Pletneva; Catherine J Lee; Sanja Ivcevic; Stefanie Sarantopoulos; Daniel Couriel
Journal:  Br J Haematol       Date:  2021-06-17       Impact factor: 8.615

Review 8.  Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment.

Authors:  Karla Strong Rodrigues; Carla Oliveira-Ribeiro; Silvia de Abreu Fiuza Gomes; Robert Knobler
Journal:  Am J Clin Dermatol       Date:  2018-02       Impact factor: 7.403

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.